On the other hand, the interaction between PD-1 (mainly expressed on T cells) and PD-L1 (mainly expressed on tumor cells) was originally thought to inhibit effector T-cell activity within the tumor microenvironment (64–67). The gene discussed is PDCD1; the disease is neoplasm.